PAUCIIMMUNE ANCA (-) EXTRACAPILLARY GLOMERULONEPHRITIS IN A PATIENT WITH SLE.

 
PAUCIIMMUNE ANCA (-) EXTRACAPILLARY GLOMERULONEPHRITIS IN A PATIENT WITH SLE.
Enrique Fleuvier
Morales López
Juan Daniel Diaz Garcia JUDANDIGAR@gmail.com Centro Medico Nacional 20 de Noviembre Nefrologia Ciudad de Mexico
Victor Manuel Ulloa Galvan vicullga@gmail.com Centro Medico Nacional 20 de Noviembre Nefrologia Mexico
Francisco Javier Hernandez Copca fhcmx90@gmail.com Centro Medico Nacional 20 de Noviembre Nefrologia Mexico
Guillermo Eduardo Ramirez Garcia edramgar@gmail.com Centro Medico Nacional 20 de Noviembre Nefrologia Mexico
Ydris Zelim Rosillo Salgado ydris_zelim@hotmail.com Centro Medico Nacional 20 de Noviembre Nefrologia Mexico
Valeria Yanez Salguero Valeria.yanezsalguero@gmail.com Centro Medico Nacional 20 de Noviembre Nefrologia Mexico
Mario Eduardo Alamilla Sanchez silenoz1@hotmail.com Centro Medico Nacional 20 de Noviembre Nefrologia Mexico
Benjamin Martin Yama Estrella benjaminyama@gmail.com Centro Medico Nacional 20 de Noviembre Nefrologia Mexico
Jose Luis Ortega Vargas joseluis_ov5@hotmail.com Centro Medico Nacional 20 de Noviembre Nefrologia Mexico
Alfredo Jimenez Bobadilla alfredojimenezb@hotmail.com Hospital Regional de Alta Especialidad de Oaxaca Nefrologia Oaxaca
Jorge Arturo Reyes Loaeza jorgenefrologia@gmail.com Hospital Regional de Alta Especialidad de Oaxaca Nefrologia Oaxaca
Oscar Aquino Arango aquinoarangooscar_92@outlook.com Centro Medico Nacional 20 de Noviembre Inmunologia y alergologia Mexico
 
 
 

Although anti-neutrophil cytoplasmic antibodies (ANCA) were first associated with primary vasculitides, it is now clear that 15-20% of lupus patients have detectable ANCA, in some cases even though histology is negative. They are the ones that make us suspect the positivity of these antibodies.

A 29-year-old female with SLE diagnosed in 2019 presented hematological and mucocutaneous disease, ANAs laboratories 1:160, with induction treatment for one year based on azathioprine, prednisone and maintenance with hydroxychloroquine. In 2021 she presents with proteinuria of 672 mg and hematuria, creatinine of 0.9 mg/dl, treatment with mycophenolic acid. One year later she had increased proteinuria 703 mg/dl, anti-DNA DS 175 U/ml (negative) C3 127 C4 25.3, ANCAs PR3 and MPO negative. She integrates hematuria proteinuria syndrome, without deterioration of renal function, eucomplementemic. Kidney biopsy active extracapillary hypercellularity, cellular crescents with active extracapillary lesion with fibrocellular crescents. Prominent and vacuolated podocytes, interstitium with patches of fibrosis with tubular atrophy, IFI with positive IGG, positive C3C granular pattern in the mesangium, determining active and chronic extracapillary proliferative glomerulonephritis with scant deposits of immune complexes (pauciimmune). By histopathology, due to cellular and fibrocellular crescents with pauciimmunity, ANCA-negative vasculitis is suspected. Therefore, treatment with cyclophosphamide was started, with subsequent improvement of proteinuria.

Crescentic glomerulonephritis is a severe form of glomerular lesion characterized by rupture of the glomerular basement membrane, cell proliferation within Bowman's space and fibrinoid necrosis, involving little or no immunoglobulin deposition at the glomerular level, which is why it is called pauciimmune. 

This type of lesions associated with SLE are very rare and more in the context of negative ANCA, we present the case to take into account this type of histological presentation.

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos